Mixed
Sarcopenic obesity, defined as the coexistence of low muscle mass/strength and high adiposity, significantly increases the risk of all-cause mortality, cardiovascular disease, and frailty compared to having either condition alone.
If you are older or have obesity, do not rely on BMI alone. Muscle loss combined with fat gain is a specific, high-risk condition that increases mortality and heart disease risk. Focus on maintaining muscle mass through resistance exercise and adequate protein intake, rather than just weight loss, which can worsen muscle loss if not managed carefully.
Sarcopenic obesity appears to be a more severe condition than obesity alone, as it is associated with a higher risk of several disorders such as cardiovascular disease, reduced bone mineral density, and all-cause mortality.
Why this rating
Supported by multiple prospective cohort studies and meta-analyses, though the paper notes a lack of standardized definitions.
Source
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
Shibo Wei et al. · Frontiers in Endocrinology · 2023
DOI 10.3389/fendo.2023.1185221
More from this paper
- Sarcopenic obesity drives cardiovascular disease and mortality through mechanisms of chronic low-grade inflammation, insulin resistance, and lipotoxicity, creating a vicious cycle with cardiovascular conditions.Good
- Management of sarcopenic obesity requires a combined approach of resistance and aerobic exercise with moderate caloric restriction and high-quality protein intake, as caloric restriction alone can exacerbate muscle loss.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →